Sagility India raised Rs 945 crore from anchor investors, including prominent mutual funds and institutions, at Rs 30 per share. The company’s IPO, entirely an offer-for-sale, opened for public subscription with a price band of Rs 28-30 per share. The IPO aims to raise Rs 2,106.60 crore at the upper end of the price band.
Posts in category All News
Around 98% of Rs 2000 notes returned says RBI (05-11-2024)
RBI stated in a latest update yesterday that 98.04 per cent of the Rs 2000 banknotes which were in circulation as of May 19, 2023, have now been returned with the total value of such notes outside the banking system coming down to Rs 6970 crore at the close of business on October 31, 2024.
Canara Bank shares 0.0% as Nifty drops (05-11-2024)
A total of 491,613 shares changed hands on the counter till 10:50AM (IST).
Raymond shares rise 4.5% post Q2 earnings (05-11-2024)
Raymond’s shares climbed 4.5% despite a 63% drop in Q2 profit, driven by strong revenue growth in real estate and engineering. Real estate revenue surged 135% and engineering revenue jumped 121%. The company highlighted project execution and strong domestic demand as key growth drivers.
Stock market update: Nifty Pharma index 0.89% in a weak market (05-11-2024)
The Nifty Pharma index was trading 0.89 per cent at 22436.25.
Ashish Kacholia portfolio stock up 1645% in 15 months; L&T to buy 21% stake (05-11-2024)
L&T in an exchange filing today informed that the company has entered into an Investment Agreement on November 5, 2024 for acquisition of up to 21 per cent stake in E2E Networks.
Bata India PAT climbs 53% YoY to Rs 52 crore in Q2 FY25 (05-11-2024)
Bata India’s consolidated net profit jumped 52.89% to Rs 51.97 crore in Q2 FY25 as against Rs 33.99 crore posted in Q2 FY24.
Share market update: Most active stocks on D-Street today in terms of volume (05-11-2024)
The NSE Nifty index was trading 15.7 points down at 23979.65
Venus Remedies secures Malaysian PIC/S Certification for pre-filled syringe facility (05-11-2024)
The approval enables Venus Remedies to expedite regulatory approvals in other PIC/S member countries through mutual recognition agreements
Gland Pharma soars as Q2 PAT rises 9% YoY to Rs 282 cr (05-11-2024)
Gland Pharma surged 10.45% to Rs 1,778.15 after the company’s net profit increased 9.39% to Rs 281.71 crore on 5.18% rise in revenue from operations to Rs 1,062.99 crore in Q2 FY25 over Q1 FY25.